John Laurie Semple

John Laurie Semple

Auto-generated profile, based on publicly available information

John Laurie Semple

Division of Plastic and Reconstructive Surgery, Women's College Hospital , Toronto, Ontario M5S 1B3

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JSJohn L Semple
John L Semple
SSSarah Sharpe
Sarah Sharpe
MMM Lucas Murnaghan
M Lucas Murnaghan
JTJohn Theodoropoulos
John Theodoropoulos
KMKelly A Metcalfe
Kelly A Metcalfe
Mobile apps are being viewed as a new solution for post-operative monitoring of surgical patients. Mobile phone monitoring of patients in the post-operative period can allow expedited discharge and may allow early detection of complications. The objective of the current study was to assess the feasibility of using a mobile app for the monitoring of post-operative quality of recovery at home following surgery in an ambulatory setting. We enrolled 65 consecutive patients (n=33, breast reconstruction surgery; n=32, orthopedic surgery) and asked them to use a mobile phone daily to complete a validated quality of recovery scale (QoR-9) and take photographs of the surgical site for the first 30 days post-op. Surgeons were asked to review patient-entered data on each patient in their roster daily. A semistructured questionnaire was administered to patients and surgeons to assess satisfaction and feasibility of the mobile device. All 65 patients completed the study. The mean number of logins was 23.9 (range 7-30) for the breast patients and 19.3 (range 5-30) for the orthopedic patients. The mean number of logins was higher in the first 14 days compared to the 15-30 days post-op for both breast patients (13.4 vs 10.5; P<.001) and for the orthopedic patients (13.4 vs 6.0; P<.001). The mean score for overall satisfaction with using the mobile device was 3.9 for breast patients and 3.7 for orthopedic patients (scored from 1 (poor) to 4 (excellent)). Surgeons reported on the easy-to-navigate design, the portability to monitor patients outside of hospital, and the ability of the technology to improve time efficiency. The use of mobile apps for monitoring the quality of recovery in post-operative patients at home was feasible and acceptable to patients and surgeons in the current study. Future large scale studies in varying patient populations are required.

1 July 2017 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
KAKathleen A. Armstrong
Kathleen A. Armstrong
PCPeter C. Coyte
Peter C. Coyte
MBMitchell Brown
Mitchell Brown
BBBrett Beber
Brett Beber
JSJohn L. Semple
John L. Semple
In the age of patient-centric care, delivery models must evolve to become more convenient for patients and cost-effective to the health system, while also maintaining a high degree of patient satisfaction and convenience. Many centers are now substituting in-person follow-up care with care delivered via telephone or a mobile app.1-6 Studies show that these remote modes of follow-up are safe and that patients are as equally satisfied with them as they are with in-person follow-up care.1-6

22 September 2014 in Journal of Medical Internet Research
Verified
Journal Article
Open access
KAKathleen A Armstrong
Kathleen A Armstrong
JSJohn L Semple
John L Semple
Peter CoytePeter Coyte
Peter Coyte
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

8 September 2010 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
ABAmy Baker
Amy Baker
HKHarold Kim
Harold Kim
JSJohn L Semple
John L Semple
DDDan Dumont
Dan Dumont
Molly ShoichetMolly Shoichet
Molly Shoichet
MJMiles Johnston
Miles Johnston
Introduction: Lymphedema is a frequent consequence of lymph node excision during breast cancer surgery. Current treatment options are limited mainly to external compression therapies to limit edema development. We investigated previously, postsurgical lymphedema in a sheep model following the removal of a single lymph node and determined that autologous lymph node transplantation has the potential to reduce or prevent edema development. In this report, we examine the potential of lymphangiogenic therapy to restore lymphatic function and reduce postsurgical lymphedema. Methods: Lymphangiogenic growth factors (vascular endothelial growth factor C (VEGF-C)) and angiopoietin-2 (ANG-2) were loaded into a gel-based drug delivery system (HAMC; a blend of hyaluronan and methylcellulose). Drug release rates and lymphangiogenic signaling in target endothelial cells were assessed in vitro and vascular permeability biocompatibility tests were examined in vivo. Following, the removal of a single popliteal lymph node, HAMC with the growth factors was injected into the excision site. Six weeks later, lymphatic functionality was assessed by injecting 125Iodine radiolabeled bovine serum albumin (125I-BSA) into prenodal vessels and measuring its recovery in plasma. Circumferential leg measurements were plotted over time and areas under the curves used to quantify edema formation. Results: The growth factors were released over a two-week period in vitro by diffusion from HAMC, with 50% being released in the first 24 hr. The system induced lymphangiogenic signaling in target endothelial cells, while inducing only a minimal inflammatory response in sheep. Removal of the node significantly reduced lymphatic functionality (nodectomy 1.9 ± 0.9, HAMC alone 1.7 ± 0.8) compared with intact groups (3.2 ± 0.7). In contrast, there was no significant difference between the growth factor treatment group (2.3 ± 0.73) and the intact group indicating improved function with the molecular factors. An increase in the number of regenerated lymphatic vessels at treatment sites was observed with fluoroscopy. Groups receiving HAMC plus growth factors displayed significantly reduced edema (107.4 ± 51.3) compared with nontreated groups (nodectomy 219.8 ± 118.7 and HAMC alone 162.6 ± 141). Conclusions: Growth factor therapy has the potential to increase lymphatic function and reduce edema magnitude in an animal model of lymphedema. The application of this concept to lymphedema patients warrants further examination.

5 December 2016 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
JSJohn L. Semple
John L. Semple
KAKathleen A. Armstrong
Kathleen A. Armstrong
Smartphone technology appears to be the next phase of development in telemedicine. With the increased focus on patient-centred care, mobile technology is being used to connect patients and their health care teams. Numerous mobile applications are available that can assist with both surgical and

1 October 2015 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
KDKristen Davidge
Kristen Davidge
KAKathleen A. Armstrong
Kathleen A. Armstrong
MBMitchell Brown
Mitchell Brown
PMPamela Morgan
Pamela Morgan
MLMary Li
Mary Li
JSJohn L. Semple
John L. Semple